英国对青少年青春期阻塞者的审判因安全问题和研究人员的偏见而暂停,推迟了重要的研究。 A UK trial on puberty blockers for youth paused over safety concerns and researcher bias, delaying vital research.

由于安全关切和治理问题,包括订正年龄要求和对高级研究员过去社交媒体职位的检查,联合王国已暂停了对性别歧视青年青春期阻塞剂的重大临床试验。 A major UK clinical trial on puberty blockers for gender-diverse youth has been paused due to safety concerns and governance issues, including revised age requirements and scrutiny of a senior researcher’s past social media posts. MAHRA停止了招聘和学习活动,列举了未经量化的长期风险和需要更有力的保障措施,尽管它强调该决定并非基于研究人员的观点。 The MHRA halted recruitment and study activities, citing unquantified long-term risks and the need for stronger safeguards, though it emphasized the decision was not based on the researcher’s views. 首席调查员因担心潜在的偏见而被撤职,这促使人们就审判的独立性进行辩论。 The lead investigator was removed over concerns about potential bias, prompting debate over the trial’s independence. 暂停治疗延缓了对治疗效果的重要研究,没有恢复治疗的明确时间表。 The pause delays critical research into the treatment’s effects, with no clear timeline for resumption.